Devers Shannon L.

Insider profile

Performance

Overall performance
2.6

Performance over holding periods
2.6
30 days 90 days 120 days
Average return -5% 8.2% 15.1%
Success rate 27% 68% 82%
Transactions
3 0% Buy
34 71% Buy
47 69% Buy
Devers Shannon L.'s trades of Ionis Pharmaceuticals Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2026-04-02 2026-04-02 PlS Planned sale
35,578 +25.3%
300.93
US$4,126,565
35,578 +25.3% 300.93 US$4,126,565
2026-03-05 2026-03-03 PlS Planned sale
19,926 -14.6%
459.83
US$3,791,046
19,926 -14.6% 459.83 US$3,791,046
2026-03-05 2026-03-03 PlS Planned sale
64,129 +16.5%
435.64
US$3,466,977
64,129 +16.5% 435.64 US$3,466,977
2026-03-05 2026-03-03 PlS Planned sale
14,321 -33.6%
79.12
US$1,133,006
14,321 -33.6% 79.12 US$1,133,006
2026-03-03 2026-03-03 PrS Proposed sale
39,014
79.50
US$3,101,613
39,014 79.50 US$3,101,613
2026-01-23 2026-01-22 PrS Proposed sale
3,977
81.34
US$323,490
3,977 81.34 US$323,490
2026-01-23 2026-01-22 PlS Planned sale
3,977 -15.0%
81.34
US$323,490
3,977 -15.0% 81.34 US$323,490
2026-01-22 2026-01-22 PrS Proposed sale
3,977
81.34
US$323,490
3,977 81.34 US$323,490
2026-01-20 2026-01-16 S Sale
8,353 -24.0%
75.95
US$634,410
8,353 -24.0% 75.95 US$634,410
2026-01-16 2026-01-16 PrS Proposed sale
8,353
76.22
US$636,626
8,353 76.22 US$636,626
2026-01-09 2026-01-07 PlS Planned sale
9,264 -34.6%
84.62
US$783,920
9,264 -34.6% 84.62 US$783,920
2026-01-09 2026-01-07 PlS Planned sale
3,829 -18.0%
84.62
US$324,010
3,829 -18.0% 84.62 US$324,010
2026-01-09 2026-01-07 PlS Planned sale
3,460 -16.5%
84.62
US$292,785
3,460 -16.5% 84.62 US$292,785
2026-01-09 2026-01-07 PlS Planned sale
2,101 -10.7%
85.36
US$179,341
2,101 -10.7% 85.36 US$179,341
2026-01-09 2026-01-07 PlS Planned sale
25,545 -59.4%
85.36
US$2,180,521
25,545 -59.4% 85.36 US$2,180,521
2026-01-07 2026-01-07 PrS Proposed sale
9,390
84.68
US$795,117
9,390 84.68 US$795,117
2025-11-28 2025-11-25 PlS Planned sale
16,777 -49.0%
80.91
US$1,357,442
16,777 -49.0% 80.91 US$1,357,442
2025-11-25 2025-11-25 PrS Proposed sale
42,322
80.91
US$3,424,273
42,322 80.91 US$3,424,273
2025-10-16 2025-10-16 S Sale
1,263 -6.7%
73.62
US$92,984
1,263 -6.7% 73.62 US$92,984
2025-10-16 2025-10-15 PlS Planned sale
6,000 -27.4%
72.94
US$437,654
6,000 -27.4% 72.94 US$437,654
2025-10-15 2025-10-15 PrS Proposed sale
15,670
75.00
US$1,175,250
15,670 75.00 US$1,175,250
2025-09-04 2025-09-03 PlS Planned sale
3,162 -17.4%
61.02
US$192,943
3,162 -17.4% 61.02 US$192,943
2025-09-03 2025-09-03 PrS Proposed sale
3,162
61.02
US$192,958
3,162 61.02 US$192,958
2025-01-17 2025-01-16 S Sale
4,267 -21.1%
32.78
US$139,855
4,267 -21.1% 32.78 US$139,855
2025-01-16 2025-01-16 PrS Proposed sale
4,267
32.70
US$139,531
4,267 32.70 US$139,531